Health News

UK trial reinfects volunteers who have had coronavirus

The University of Oxford said Monday it has launched a trial in which people who have already had COVID-19 are deliberately reinfected. The carefully controlled study will look at the kind of immune response mounted by the volunteers. The scientists will know “exactly when the second infection occurs, and exactly how much virus they got,” […]

Health News

Gout drug tested as coronavirus treatment in large UK trial

Americans remain hopeful for coronavirus vaccine following the Thanksgiving holiday Internal medicine physician Dr. Shoshana Ungerleider calls recent vaccine developments ‘truly incredible.’ An anti-inflammatory drug widely used to treat gout and other conditions is the latest to be added to a large-scale trial in the U.K. that is investigating potential treatments for coronavirus. Researchers leading […]

Health News

Moderna coronavirus vaccine trial volunteer details experience: Nothing to fear but minor side effects

Moderna coronavirus vaccine trial volunteer shares experience Moderna COVID-19 vaccine volunteer, Jack Morningstar, shares trial experience, urges others to take on ‘Fox & Friends.’ A Moderna coronavirus vaccine trial volunteer from the University of North Carolina at Chapel Hill shared his experience with "Fox & Friends" Friday, urging everyone to get it to save lives and […]

Health News

Results from the COBRA-REDUCE trial reported

For patients undergoing percutaneous coronary intervention (PCI) that also require oral anticoagulation, treatment with a nanotechnology polymer-coated stent plus 14-day dual anti-platelet therapy (DAPT) did not reduce bleeding or establish non-inferior outcomes for thrombotic events compared with a drug-eluting stent (DES) and standard three or six-month DAPT therapy. Findings were reported today at TCT Connect, […]

Health News

Results from the VOYAGER PAD Trial reported

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether […]